Hospira Vinorelbine Tartrate for Injection 50 mg/5 mL vial

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

vinorelbine tartrate, Quantity: 13.85 mg/mL

から入手可能:

Hospira Australia Pty Ltd

INN（国際名）:

Vinorelbine tartrate

医薬品形態:

Injection

構図:

Excipient Ingredients: water for injections

投与経路:

Intravenous

パッケージ内のユニット:

1 x 5 mL vial

クラス:

Medicine Listed (Export Only)

処方タイプ:

Not scheduled. Not considered by committee

適応症:

Vinorelbine tartrate is indicated in the treatment of advanced non-small cell lung cancer (NSCLC), as a single agent or in combination. Vinorelbine tartrate is also indicated for the treatment of patients with metastatic breast cancer who have failed standard first-line chemotherapy for metastatic disease. In addition, vinorelbine tartrate is indicated for the treatment of patients with metastatic breast cancer who have relapsed within 6 months of anthracycline-based adjuvant therapy.

製品概要:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

認証ステータス:

Licence status A

承認日:

2008-05-05